A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Clinical trial NCT00787332 · TERMINATED

Trial details

NCT number: NCT00787332
Sponsor: Canyon Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Suspected Heparin-Induced Thrombocytopenia

Start date: 2008-09-01
Primary completion: 2009-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.